Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Clinical Trial to Assess Whether the Duration of Cotrimoxazole Preventive Therapy in HIV Patients With CD4 Counts >350 CD4 Cells/µL by Antiretroviral Treatment Influences the Rate of Carriage of Multidrug-resistant Bacteria

NCT03087890 is registered in ClinicalTrials.gov with University of Bergen as lead sponsor.

NCT NCT03087890
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03087890 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Clinical Trial to Assess Whether the Duration of Cotrimoxazole Preventive Therapy in HIV Patients With CD4 Counts >350 CD4 Cells/µL by Antiretroviral Treatment Influences the Rate of Carriage of Multidrug-resistant Bacteria
Lead sponsor
University of Bergen
Phase
Phase 4
Overall status
Completed
Start date
March 30, 2017
Completion date
July 25, 2019
Enrollment
537 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic side effect, hiv-1-infection, opportunistic infections, pneumocystis pneumonia, preventive therapy